Works matching AU Hayashi, Kazumi
Results: 20
CD3+, CD4–, CD8–, TCRαβ–, TCRγδ+ Granular Lymphocyte Proliferative Disorder without Lymphocytosis and Clinical Symptoms.
- Published in:
- Acta Haematologica, 2000, v. 104, n. 1, p. 54, doi. 10.1159/000041073
- By:
- Publication type:
- Article
Expression of immune checkpoint molecules of T cell immunoglobulin and mucin protein 3/galectin-9 for NK cell suppression in human gastrointestinal stromal tumors.
- Published in:
- Oncology Reports, 2015, v. 34, n. 4, p. 2099, doi. 10.3892/or.2015.4149
- By:
- Publication type:
- Article
Gemcitabine treatment enhances HER2 expression in low HER2-expressing breast cancer cells and enhances the antitumor effects of trastuzumab emtansine.
- Published in:
- Oncology Reports, 2015, v. 34, n. 1, p. 504, doi. 10.3892/or.2015.3974
- By:
- Publication type:
- Article
Therapeutic effects of interleukin-1 receptor-associated kinase 4 inhibitor AS2444697 on diabetic nephropathy in type 2 diabetic mice.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2020, v. 393, n. 7, p. 1197, doi. 10.1007/s00210-020-01816-2
- By:
- Publication type:
- Article
Renoprotective effects of novel interleukin-1 receptor-associated kinase 4 inhibitor AS2444697 through anti-inflammatory action in 5/6 nephrectomized rats.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2014, v. 387, n. 10, p. 909, doi. 10.1007/s00210-014-1023-z
- By:
- Publication type:
- Article
Effects of gene polymorphisms on the risk of severe hyponatremia during DCF chemotherapy for patients with esophageal squamous cell carcinoma.
- Published in:
- Oncology Letters, 2018, v. 16, n. 4, p. 5455, doi. 10.3892/ol.2018.9236
- By:
- Publication type:
- Article
Development of Rapid Debinding Treatment Using Superheated Steam and Debinding Behavior for Alumina Molded Bodies.
- Published in:
- Journal of the Japan Society of Powder & Powder Metallurgy / Funtai Oyobi Fummatsu Yakin, 2019, v. 66, n. 6, p. 275, doi. 10.2497/jjspm.66.275
- By:
- Publication type:
- Article
Biological properties of a specific Gα<sub>q/11</sub> inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress.
- Published in:
- British Journal of Pharmacology, 2006, v. 148, n. 1, p. 61, doi. 10.1038/sj.bjp.0706711
- By:
- Publication type:
- Article
Encryption of agonistic motifs for TLR4 into artificial antigens augmented the maturation of antigen-presenting cells.
- Published in:
- PLoS ONE, 2017, v. 12, n. 11, p. 1, doi. 10.1371/journal.pone.0188934
- By:
- Publication type:
- Article
Clinical benefits of adding olanzapine to 5-HT<sub>3</sub> receptor antagonist, NK<sub>1</sub> receptor antagonist, and dexamethasone for the prevention of nausea and vomiting in highly emetogenic chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology
- Published in:
- International Journal of Clinical Oncology, 2025, v. 30, n. 1, p. 27, doi. 10.1007/s10147-024-02663-4
- By:
- Publication type:
- Article
Efficacy and safety of multi-day antiemetic treatment for patients undergoing multi-day chemotherapy: a systematic review of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology.
- Published in:
- International Journal of Clinical Oncology, 2025, v. 30, n. 1, p. 17, doi. 10.1007/s10147-024-02652-7
- By:
- Publication type:
- Article
Defining the clinical benefits of adding a neurokinin-1 receptor antagonist to control chemotherapy-induced nausea and vomiting in moderately emetogenic chemotherapy: a systematic review and meta-analysis of the clinical practice guidelines for antiemesis 2023 from the Japan society of clinical oncology
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 11, p. 1616, doi. 10.1007/s10147-024-02623-y
- By:
- Publication type:
- Article
Non-pharmacological treatments for anticipatory nausea and vomiting during chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 889, doi. 10.1007/s10147-024-02536-w
- By:
- Publication type:
- Article
2023 Japan Society of clinical oncology clinical practice guidelines update for antiemesis.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 873, doi. 10.1007/s10147-024-02535-x
- By:
- Publication type:
- Article
Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 12, p. 1499, doi. 10.1007/s00262-016-1905-7
- By:
- Publication type:
- Article
Vaccination with vascular progenitor cells derived from induced pluripotent stem cells elicits antitumor immunity targeting vascular and tumor cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 5, p. 459, doi. 10.1007/s00262-014-1531-1
- By:
- Publication type:
- Article
Combinatorial Contextualization of Peptidic Epitopes for Enhanced Cellular Immunity.
- Published in:
- PLoS ONE, 2014, v. 9, n. 10, p. 1, doi. 10.1371/journal.pone.0110425
- By:
- Publication type:
- Article
Augmentation of Antitumor Immunity by Fusions of Ethanol-Treated Tumor Cells and Dendritic Cells Stimulated via Dual TLRs through TGF-β1 Blockade and IL-12p70 Production
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0063498
- By:
- Publication type:
- Article
Long-term outcomes of oligometastatic breast cancer patients treated with curative intent: an updated report.
- Published in:
- Breast Cancer (13406868), 2021, v. 28, n. 5, p. 1051, doi. 10.1007/s12282-021-01240-1
- By:
- Publication type:
- Article
Gemcitabine enhances rituximab-mediated complement-dependent cytotoxicity to B cell lymphoma by CD20 upregulation.
- Published in:
- Cancer Science, 2016, v. 107, n. 5, p. 682, doi. 10.1111/cas.12918
- By:
- Publication type:
- Article